Ryan Specialty Holdings, Inc. (NYSE:RYAN) Position Boosted by GAMMA Investing LLC

GAMMA Investing LLC grew its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 38.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,725 shares of the company’s stock after purchasing an additional 476 shares during the period. GAMMA Investing LLC’s holdings in Ryan Specialty were worth $111,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Principal Financial Group Inc. increased its position in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after acquiring an additional 509,548 shares in the last quarter. Jennison Associates LLC increased its position in shares of Ryan Specialty by 60.2% in the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after acquiring an additional 385,366 shares in the last quarter. Eagle Asset Management Inc. increased its position in shares of Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after acquiring an additional 335,180 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock worth $62,286,000 after acquiring an additional 286,380 shares in the last quarter. Finally, Driehaus Capital Management LLC purchased a new position in shares of Ryan Specialty in the second quarter worth approximately $16,313,000. Institutional investors own 84.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on RYAN shares. Barclays raised their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Finally, Bank of America lifted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and an average target price of $75.00.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock opened at $62.43 on Friday. The firm has a fifty day simple moving average of $68.30 and a 200-day simple moving average of $65.59. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 1-year low of $42.04 and a 1-year high of $75.97. The stock has a market capitalization of $16.35 billion, a price-to-earnings ratio of 81.08, a PEG ratio of 1.52 and a beta of 0.72.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. During the same period in the previous year, the company earned $0.32 earnings per share. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. On average, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the transaction, the director now owns 65,100 shares of the company’s stock, valued at approximately $4,387,089. The trade was a 34.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 126,936 shares of company stock worth $8,536,282. 11.10% of the stock is owned by insiders.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.